In one paragraphReview in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Aigerim ZhakypbekResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Lespek KutumbetovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Gulnur KuzembekovaDepartment of Microbiology, Virology and Immunology, Faculty of Veterinary Science and Zooengineering, Kazakh National Agrarian Research University, Almaty 050010, Kazakhstan.
Kamshat ShorayevaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Nurlan KozhabergenovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0001-6299-9399 Bekbolat UsserbayevResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-4615-1328 Gulnur NakhanovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Kuanysh JekebekovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Gaukhar ShynybekovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-6976-1540 Akbope AbdykalykResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-1998-8798 Aknur UlankyzyResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Temirlan BaiseitResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Balzhan MyrzakhmetovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.
Olga ChervyakovaResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0002-7954-6246 Kuandyk ZhugunissovResearch Institute for Biological Safety Problems, National Holding QazBioPharm, Gvardeiskiy 080409, Kazakhstan.ORCID 0000-0003-4238-5116 Funding
Ministry of Healthcare of the Republic of Kazakhstan BR28712529
6 · The paper itselfAbstract
Orthopoxviruses are zoonotic DNA viruses of continuing public health importance, as highlighted by recent global mpox outbreaks. The high antigenic similarity among orthopoxviruses enables cross-reactive immune responses but complicates the development of serological diagnostic systems for serosurveillance, assessment of previous exposure, evaluation of vaccine-induced immunity, and species differentiation. This review summarizes current knowledge regarding the structure, biological functions, and diagnostic and vaccine potential of major orthopoxvirus recombinant antigens. Particular attention is given to the genomic organization of
Indexed as
Antigens, ViralOrthopoxvirusPoxviridae InfectionsRecombinant ProteinsViral ProteinsAnimalsAntibodies, ViralHumansPhylogenyProtein Subunit VaccinesViral VaccinesAntibodies, ViralAntigens, ViralProtein Subunit VaccinesRecombinant ProteinsViral ProteinsViral VaccinesimmunogenicityIMV and EEV antigensmonkeypox virusorthopoxvirusphylogenetic analysisrecombinant antigensserological diagnosticssubunit vaccines
Identifiers
PMID42655681
PMCPMC13517126
What OpenQuestion holds
Textmetadata
Read underepoch 390